Tags Posts tagged with "cannabis stock"

cannabis stock

0 1273
marijuana_glaucoma
 

PotNetwork Holding, Inc. (POTN) Executes Diversification Strategy to Expand Position into the Cannabis Sector

PotNetwork Holding, Inc. ( OTC : POTN ), (“Company”) is very pleased to announce the reacquisition of PotNetwork.com, an online resource originally designed to become a leading industry specific news and content provider for the cannabis marketplace.


Click Here Now To Read (POTN) Release


Marijuana Stocks The Good The Bad The Ugly For Biotech

Although the biotech industry is poised to be one of the greatest beneficiaries of the legal cannabis movement, investors must be cautious with many of the companies focused on this opportunity. While opportunity is vast, it is also expensive and many of these companies do not have the capital needed to execute on its strategy. We have highlighted three biotech cannabis firms below in order of favorability and will continue to monitor how they execute on their plan from here.


Click Here Now To Read Full Article


 

 

Will These Marijuana Stocks Be The Future Of The Industry

Unless you’ve been hiding under a rock somewhere, you’re probably aware that the marijuana industry is booming. With more than half the U.S. legalizing medical marijuana, several legalizing recreational marijuana, and Canada recently making recreational marijuana legal nationwide, demand is greater than ever. Promising marijuana-based drugs could be on the market in the near future.


Click Here Now To Read Full Article


0 1294
Marijuana-Stocks-Cannabis-nug-18
 

PotNetwork Holding, Inc. (POTN) Restocks Popular CBD Chill Gummies Inventory

 

PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce that Diamond CBD’s Chill Gummy line has been restocked and is once again available for sale. “We are happy to announce that our popular Gummy Bears and other gummy edibles once again grace our shelves. As a result of an overwhelming influx of inquiries, we have opted to publicly announce that our gummies are stocked, available and ready to be shipped,” stated Maria Gomez, Regional Vice President of Sales, Diamond CBD.

 

 


Click Here Now To Read (POTN) Release


Why Should You Invest in Marijuana Stocks ?

When it comes to investing in marijuana (specifically medical marijuana) there are many reasons why it’s a smart move. Because of the new nature of the market, the potential for gain remains incredibly high as predictions for future charts project upwards of $5 billion in growth in the next decade. The time to get in is now.


Click Here Now To Read Full Article


 

 

One CBD Company That Could Be Outpacing Industry Leaders

Among the many segments of the marijuana industry that marijuana stock traders pay attention to, CBD or cannabidiol has taken on a major role. This is not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market is projected t to see, CBD companies are in the spotlight


Click Here Now To Read Full Article


 

0 854
marijuana stocks
 

Marijuana Stocks Could Fly If This Measure Gets Passed

 

U.S. Attorney General Jeff Sessions is reportedly trying to build support to go after companies that sell marijuana in states that have legalized the drug. However, while the executive branch contemplates fighting marijuana, the legislative branch is taking the opposite approach.

 

 


Click Here Now To Read Full Article


 

What To Know When Investing In Marijuana Stocks

 

 

Legal Marijuana is the fastest growing industry in the United States. In 2016, cannabis sales in North America went up 30% from 2015 to reach $6.7 billion.

And looking into the future with more states, Canada and countries around the world making their way toward legalization this already extraordinary speed of growth is actually set to pick up. Canada’s recent decision to legalize recreational cannabis by next summer is expected to create a $23 billion industry that could be bigger than beer and wine.

 

 


Click Here Now To Read Full Article


 

 

 

Working In The Marijuana Industry Is Tougher Than You Think

Those who work in the marijuana industry with in the United States were to ever come together, there would be more of you than there are massage therapists, bakers or other classic paths to the middle class.

 


Click Here Now To Read Full Article


 

0 3689
marijuana stock

Among the many segments of the marijuana industry that marijuana stock traders pay attention to, CBD or cannabidiol has taken on a major role. This is not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market is projected t to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that has been attracting the attention of marijuana investors has been Potnetwork Holdings, Inc. (POTN).  Now don’t let the name fool you, this company, through its subsidiary First Capital Venture Co., owns Diamond CBD Inc.;

Over the last few months, POTN has been breaking barriers with its CBD brand while also hitting major milestones for the better part of the first half of the year.  What could be best of all is that 2017 may already have the stage set for a record setting period in POTN’s company history.

Big Growth Already In Play?

In May of this year (2017) the company announced that it had realized first quarter figures that exceeded expectation by over $100,000, for a total of $1,858,347.48. They also established a merchandising pipeline of 7,000 authorized retail vendors through its distribution channels, which puts Diamond CBD at approximately 10,000 stores in the United States.

If this wasn’t enough, POTN further catapulted off of this first quarter momentum by recognizing over $2million from April to mid-May with a pace set to outshine the first quarter figure by a relatively large margin. Even assuming this rate of revenue generation and accounting for zero growth or contraction in revenues, POTN could be an $11million company by year’s end. Again this is assuming the company holds this course and does about $1million in revenue per month.

Let’s compare just by Revenue Figures Alone From Most Recent Annual Filings:

√ Medical Marijuana, Inc. 

$8.00m (Annual, 2016) Market Cap: $264.7M

√ Rocky Mountain High Brands, Inc.

$1.08m (Annual, 2016)   Market Cap: $ 53.4M

√ mCig, Inc.  

$4.5m (Annual, 2017)  Market Cap: $ 70.0M

√ Axim Biotechnologies, Inc.

$0.047m (Annual, 2016) Market Cap: $551.4M

Now look at these figures, the multiples are astronomical compared to their market caps:

  • mCig trades at roughly 15.5 times revenue
  • Medical Marijuana Inc. trades at nearly 33 times revenue
  • Rocky Mountain trades over 49.4 times revenue
  • Axim is trading at an astronomical 11,732 times revenue!

Now look at the same situation for Potnetwork. We can look at the 2016 annual for apples to apples comparison but the real story comes when you consider that Diamond CBD is now its subsidiary (which we’ll get into in a moment).

√ Potnetwork Holding, Inc.     

$1.03m    (Annual, 2016)   Market Cap: $38.2M

Even with last year being a slower year for the company, which could be attributed to the company’s future outlook and its uncertainty, Potnetwork had only traded at roughly 4 times revenue.

Now, let’s take into account the company’s last few months of announcements. By the figures given, it’s assumed that as of the end of May, Potnetwork revenue was in the ballpark of roughly $3.86m on a conservative estimate based on Q1 revenue and May revenues of over $1million: first quarter 2017 revenue of $1,858,347.48, “over $1 Million in April,” and “over $1Million for May.”

Price Target Given: $0.25

Being that this will be the first time that Diamond’s operations will be under the POTN flag, we can look at a brief snapshot of the company, at least from a first half standpoint of this year.

Even by just assuming that this company sees zero growth ahead and an outstanding share count of even 600m, at current prices of roughly $0.08, POTN would be a $48m market cap company with revenues of roughly $3.86m; only 12 times revenue.

But so far this year, a “zero growth” scenario has not been the case at all. In fact, based on recent announcements, growth for the company has been very pronounced so far. This is most likely a big reason why analysts are finding that the valuation for POTN is low right now. SeeThru Equity initiated coverage on Potnnetwork Holdings and recently gave a price target of $0.25. Meanwhile, the company continues to hit the convention circuit to build attention around the investment side of Potnetwork & Diamond CBD’s company as well as the actual product side of the business through countless tradeshow appearances.

And just recently the company announced that it has sold 80,000 Chill gummies since taking to the roadshow circuit. And currently POTN is “re stocking” over a two-week period to re-up its inventory of this brand.

The takeaway? In our opinion, compared to other presumed “industry leaders,” POTN is still trading at a fraction of the revenue multiple that these other companies are. Additionally, based on announcements, it doesn’t appear that the company, with Diamond CBD, is closing the doors and stopping its revenue growth anytime soon. This could be one of the more, if not the most undervalued CBD stocks in the market right now and the fundamentals show rapid growth projected along the way.

 “We are ecstatic with our results. We have learned to set our expectations high. As a result of the timing of CBD’s growing popularity and the quality of our products, our products are consistently met with reseller and consumer enthusiasm resulting in continuous escalating sales.”

-Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc.

The opportunity for taking advantage of the growth that CBD is beginning to see could be important to take into consideration.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.

Think about this for a moment: POTN is already growing and is expecting to continue this growth for the year, according to several announcements already made during the last few months…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth.

Having already come off of a banner quarter, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to during the second half of 2017.

 


Pursuant to an agreement between MAPH and Potnetwork Holdings, Inc., we were hired for a period of 1 month from 6/1/2017 – 7/1/2017 to publicly disseminate information about (POTN) including on the Website and other media including Facebook and Twitter. We are being paid $21,000 (CASH) by Potnetwork Holdings, Inc. via First Capital Ventures, Inc. an affiliate company for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (POTN) which we purchased in the open market.We may buy or sell additional shares of (POTN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

marijuana stocks

A Revolutionary Cannabis Investment?

Some of the greatest investment minds in the world say, “You invest in management.” And since the birth of MarijuanaStocks.com, few management personnel have shined brighter than Cannabis Wheaton Income Corp. CEO Chuck Rifici. Mr. Rifici has accomplished with Cannabis Wheaton something that no other cannabis industry CEO has. The business model he has implemented is something that we feel every marijuana investor MUST know about. Cannabis Wheaton (KWFLF)(CBW.V) provides a very unique opportunity for marijuana investors by greatly reducing risk while still maintaining tremendous upside potential.

But before we explain the Cannabis Wheaton business model and why we feel EVERY investor should know about it, let’s first take a look at Chuck Rifici. Because as we said earlier, “you invest in management.” And there may not be a more recognizable managerial figure who has done more for the marijuana industry than Mr. Rifici.

Invest in Management

Chuck Rifici is responsible for co-founding and taking public the largest full-scale producer of government-sanctioned marijuana as its CEO in April 2014; a company by the name of Tweed Inc. whose name later changed to Canopy Growth Corp. (TWMJF)(WEED.TO). To this day, Canopy Growth remains the largest public cannabis company with a staggering market cap of approximately $1Billion. In 2016, WEED hit $17.86 approximately 550% higher than the IPO price. It is widely agreed to be the most successful marijuana company to go public and is seen as the benchmark and leader of the industry.

Take a look at how WEED stock has performed over the last 2 years:

marijuana stocks

When considering an investment in any company, it’s important to look at the management team. Who is leading the ship? Is this their first rodeo? Or have they already proven successful in bringing a company to market that has built shareholder value? Well, Chuck Rifici’s track record with co-founding Tweed speaks for itself and gives Cannabis Wheaton shareholders confidence that they have a marijuana industry trailblazer leading their ship.

But Rifici’s resume is filled with much more than just Tweed. In 2011, Rifici was appointed CFO of the Liberal Party of Canada by interim party leader Bob Rae. In 2014, Rifici was also named to the Top Forty under 40 by Ottawa Business Journal, named Alumnus of the Year by the University of Ottawa Faculty of Engineering, and received the Exceptional New Business Award by the Ottawa Chamber of Commerce.

Rifici also sat on the Board of marijuana starlets Supreme Pharmaceuticals (SPRWF) (SL.CN), Aurora Cannabis (ACBFF) (ACB.V), and CannaRoyalty (CNNRF) (CRZ.V). These board positions helped Rifici keep his ear to the ground, expand his network, and gain insight to the marijuana industry in both Canada and the U.S. He actually just resigned from his Supreme Pharma and Aurora Cannabis Board seats because of a slight conflict of interest but mostly to focus all of his time and energy towards building Cannabis Wheaton into a revolutionary cannabis company.

Cannabis Wheaton’s Streaming Model—Revolutionizing Cannabis Investment

Cannabis Wheaton is the first company to bring a streaming business model to the marijuana industry. This unique model can greatly reduce risk for investors while maintaining tremendous upside potential from a booming industry. Streaming business models are normally found in the mining industry and refer to when a company strikes a deal with a miner to purchase all or part of its future metal production in exchange for upfront cash. Perhaps the most notable example is silver giant Silver Wheaton (NYSE: SLW). This works well because mining is a very cash intensive business and requires a lot of upfront capital. And the cannabis industry is about to undergo a massive expansion that will be an serious capital burden on current marijuana producers.

Rifici has said that the marijuana industry must increase total production by 10 times the current rate in order to keep pace with the increased demand for marijuana once the drug is legalized for recreational use. Producers are barely keeping up with cannabis demand from just medical marijuana users, never mind when legal recreational use goes into effect.

Currently, there is only 1.4 million square feet of licensed medical marijuana production facilities in Canada. According to Rifici, 14 million square feet is needed to satisfy the upcoming demand. Such a massive expansion is a major financial burden and carries great risk for companies trying to expand so much so quickly. And that is where the opportunity lies for Cannabis Wheaton.

“We’re going to see tremendous growth in the industry…There have been a lot of announced expansions that fill maybe a third of that gap. But there’s still 6 or 7 million square feet that needs to be built out,” said the Rifici.

Under the streaming model, Cannabis Wheaton will provide marijuana producers with the necessary capital to expand their operations in exchange for a minority equity stake in the company and a portion of their future production at an agreed upon discounted price. The company will also provide their partners with guidance and expertise on facility construction, cultivation, and the licensing process. Rifici has brought to Wheaton several of the early key members of Tweed including the top cannabis legal team in Canada that has helped half a dozen Licensed Producers (LPs) obtain their licenses.

Cannabis Wheaton has already signed 16 streaming deals with 14 partners across 6 different provinces of Canada. Their partners’ credentials include:

  • 2 sales licenses.
  • 3 cultivation licenses.
  • 4 affirmation letters.
  • 5 advanced pre-affirmation stage applicants.

Through these agreements, Cannabis Wheaton already has access to 1.3 million square feet of cultivation by 2019, 30,000 registered medical marijuana patients, and nearly 40 medical cannabis clinics.

One agreement we feel worth mentioning specifically is the company’s deal with Broken Coast Cannabis Ltd., a British Columbia based medical cannabis producer that has established itself as a top provider of high grade cannabis products. Broken Coast’s clean tech production methods and systems deliver consistent premium cannabis. The company was also recently awarded one of the few 18-month Access to Cannabis for Medical Purposes Regulation (ACMPR) licenses, which is a testament to its compliance record.

Broken Coast and its entities will utilize the experience and capital of Cannabis Wheaton to accelerate expansion and scale production in a short period of time. Under the terms of the agreement between the companies, Broken Coast will source a proposed site to complement their current site. The parties expect the new location to accommodate at least 100,000 square foot state-of-the-art cannabis cultivation facility.

Broken Coast will operate the new facility in accordance with its industry best practices and the two companies will share the proceeds with Cannabis Wheaton receiving 49% of the product output.

5 Reasons to Consider Cannabis Wheaton

  1. Licensed Producer Diversification- Because the company is working with such a wide range of cannabis cultivation companies and receiving both an equity stake in those companies and a percentage of the end product, shareholder risk is spread out amongst several companies rather than just one.
  2. Exposure to Tremendous Upside- Usually, reducing risk results in reduced potential reward, too. But not in this case. Even with the reduced risk, shareholders are exposed to the explosive industry expansion that Rifici explained as being a 10x expansion. Current cannabis revenue numbers in Canada will pale in comparison to what we see once legal recreational use goes in effect. Cannabis Wheaton will hold an equity stake in many producers as well as owning portions of the end product at a discounted price.
  3. Geographic Diversification- Cannabis Wheaton has signed agreements with partners across 6 different provinces in Canada. This brings exposure to several different markets and acts almost as a loophole for the company to take advantage of a few question marks the industry has regarding distribution.
  4. Proven Business Model- The streaming business model has already been proven successful for some of the largest metal miners in the world. Silver Wheaton, a streaming company with a market cap of approximately $10Billion, went to this model because they generally have a bullish outlook on the price of silver. So, it makes sense for them to fund a miner’s drilling operations and expansion to purchase the future metal output at a steep discount. Similarly, Rifici and Cannabis Wheaton have a bullish outlook on the production rate and revenue numbers for marijuana in Canada expecting a 10x expansion of the industry. So, it makes sense to help fund the expansion in return for equity ownership and a portion of the end product.
  5. Successful Management- The team behind Cannabis Wheaton has already taken the largest producer of government-sanctioned marijuana public. And it was and remains the most successful IPO in the cannabis space and true leader of the industry. 

Conclusion

Ever since Rifici co-founded Tweed and brought the cannabis juggernaut public in 2014, investors wondered what his next project would be. Rifici said he is proud of what he built with Tweed but was ready to put the past behind him.

“I’m essentially moving on to what I think are far better opportunities in the space,” said the Cannabis Wheaton CEO.

It’s hard to imagine what opportunities could be more successful than a $1Billion market cap, top marijuana producing, cannabis leader that gained 550% from its IPO. But if anyone knows an opportunity in the marijuana space when they see one it’s Chuck Rifici.

Licensed Producers are already having trouble keeping up with demand from about only 130,000 registered medical marijuana patients. When legal recreational use goes into effect, demand is going to skyrocket. The current 1.4 million square feet of cultivation facility space simply isn’t going to cut it. Not even close. The entire industry is racing to undergo a massive expansion that will see cultivation space increase by about 10 times. That type of expansion is extremely costly and carries great risk for individual producers.

However, with their streaming business model, Cannabis Wheaton is de-risking the expansion while still giving investors exposure to the booming industry growth. With 16 agreements already inked with 14 different partners across 6 different provinces, Cannabis Wheaton could very well be revolutionizing the way investors capitalize on the cannabis industry.

 


Disclaimer: Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 10096

When We Connect the Dots, You Profit 
Connect the Dots Articles Have Returned 9,932% for Our Readers 

Over the last couple years, as the marijuana industry has taken flight, it has been our mission to help our readers make money from cannabis. Every once in a while we publish a “Connect the Dots” article highlighting a company or group of companies that we believe have tremendous near-term upside potential. By identifying these companies and providing insight and research otherwise unavailable to the mainstream investor, we have been able to help our readers gain as much as 9,932% in about two and a half years. That is the combined gain percentage that all of our Connect the Dots companies experienced in the weeks and months after we published an article. Let’s take a look at some of our biggest gainers:

*CannaGrow Holdings (CGRW); previously BizAuctions (BZCN) click here for article
Connect the Dots published on 10/8/14 at $0.053
CGRW hit $3.45 on 10/18/16
6,409% gain 

*Rocky Mountain High (RMHB); previously Totally Hemp Crazy (THCZ) click here for article
Connect the Dots published on 12/18/14 at $0.0115
THCZ hit $0.32 on 4/1/15
2,683% gain

*Future Farm Technologies (FFRMF); previously Arcturus Growthstar Technologies (AGSTF) click here for article
Connect the Dots published on 10/4/16 at $0.137
FFRMF hit $0.541 on 2/22/17
295% gain

*Vitality Biopharma (VBIO) click here for article
Connect the Dots published on 12/6/16 at $1.01
VBIO hit $4.24 on 12/27/16
320% gain

These are just a few of our previous Connect the Dots highlights. And as you can see, the track record speaks for itself. It is our goal to literally connect the dots for our readers to help identify opportunity in this budding industry. And thus far we have done more than just identify opportunity; we have helped some earn a small fortune.

Now we know it’s impossible to have captured all of the 9,932% gains. So let’s say you were able to capture just half. A $5,000 investment would be worth $248,300. Again, that’s if you only captured half of the total gains.

The marijuana industry is at a very interesting stage of its development right now. Even with nearly 10,000% gains in the books, we still feel that we’ve only seen the tip of the iceberg. And it’s one mighty iceberg. We hope that you are happy with the content we provide and continue to read our articles on a daily basis. Because you never know when the next cannabis opportunity will bud.


Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.Pursuant to an agreement between MAPH and a non affiliate third party, we were previously hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

    0 4058
    marijuana stocks

    VBIO has now gained 42% since we re-initiated coverage on the company on April 20th at $1.93. On May 3rd, VBIO rocketed out of the gate hitting a high of $2.74 after announcing the addition of key clinical advisors in gastroenterology. This comes just days after we sent an email to subscribers saying to look for a break above resistance as momentum could pick up soon. And our timing was perfect.

    This is the second time we initiated coverage on this company and the results are beginning to look a lot like the first time. Our initial coverage began back on December 6, 2016, at $1.01. Within less than 1 month, VBIO exploded 320%. Now, here we are less than two weeks into our second round of coverage and VBIO has already gained 42%.

    cannabis stock

    Check out the experience of the advisors the company just added:

    Vitality Biopharma Adds Key Clinical Advisors in Gastroenterology

    Vitality Biopharma announced Dr. Douglas A. Drossman and Dr. Mark Gerich as clinical advisors with expertise in gastroenterology and treatment of digestive disorders.

    Douglas A. Drossman, M.D., is a founder and now President of the Rome Foundation, an independent nonprofit research organization dedicated to improving the lives of people with functional GI disorders. Dr. Drossman is an Emeritus Professor of Medicine and Psychiatry at the University of North Carolina (UNC) School of Medicine. He is a recognized expert in the diagnosis and treatment of narcotic bowel syndrome, a severe form of opiate-induced abdominal pain, having authored seminal publications describing this condition. Dr. Drossman established a program of research in functional GI disorders at UNC more than 25 years ago and has published more than 500 books, scientific articles, and abstracts. He received his MD from Albert Einstein College of Medicine in 1970 and completed medical residencies at the University of North Carolina School of Medicine and the New York University-Bellevue Medical Center.

    Mark Gerich, M.D., currently serves as the Clinical Director of the University of Colorado Crohn’s & Colitis Center and conducts clinical and translational research focused on the pathogenesis and treatment of inflammatory bowel disease (IBD). He received his undergraduate degree from Cornell University and a dual MD/MBA degree from McGill University in Montreal, Quebec, Canada. Dr. Gerich received his internal medicine training at the University of California Davis Medical Center and completed his fellowship in gastroenterology and hepatology at the University of Colorado in 2011. After completing an advanced IBD fellowship at Cedars-Sinai Medical Center in Los Angeles, Dr. Gerich joined the faculty in the Division of Gastroenterology and Hepatology at the University of Colorado.

    These key additions add to an already attractive story unfolding with Vitality Biopharma. And we were some of the first ones to identify the opportunity. Our timing continues to be spot on so stay tuned for further updates regarding VBIO.

     


     

    Disclaimer: Pursuant to an agreement between MAPH and a non affiliate third party, we were previously hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information

      0 2771
      Marijuana-stocks-biotech

      Wow, another record volume day for Vinergy Resources (VNNYF). This action has definitely got our attention. We re-initiated coverage of this company on May 1, 2017, at $0.33 and in just three days we have already seen a record setting volume day TWICE and a steady 27% climb.

      cannabis stock VNNYF

      Today, May 3rd, VNNYF made a new 3-day high of $0.42 on record volume. We are getting a lot of messages from subscribers asking about what the acquisition of MJ Biopharma could mean for Vinergy and its shareholders. To get up to speed, read this article to see what investors should know about the pending acquisition of MJ Biopharma:

      The Significance of the MJ Biopharma Acquisition – What Investors Should Know

      As most of you already know, trading of Vinergy on the Canadian stock exchange under symbol VIN.CN has been halted pending a fundamental change in the company. It is our opinion and assumption that this ‘fundamental change’ could be the completion of the MJ Biopharma acquisition that the company mentioned months ago. We cannot be certain of this, but there is a lot of buzz circulating right now about this potential acquisition and the recent trading activity on the U.S. side in VNNYF. If you haven’t done so already, familiarize yourself with Vinergy Resources (VNNYF) and MJ Biopharma. Because if this acquisition is completed, the most informed investors will be in the best position.

       


       

       

      Disclaimer: Pursuant to an agreement between MAPH and a non-affiliate third party, we were hired for a period of 1 month from 5/1/2017 – 6/1/2017 to publicly disseminate information about (VNNYF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (VNNYF) which we purchased in the open market.We may buy or sell additional shares of (VNNYF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

       

      0 2444
      marijuana

      Another strong day in the books for Vinergy Resources (VNNYF) as the stock gained 11% today, May 2, 2017. With this type of action, everyone should be starting to take notice and paying attention. Volume was again at record levels which could be signaling that investors are starting to act ahead of the possible completed acquisition of MJ Biopharma. VNNYF has now gained 23% since we re-initiated coverage on the company just two days ago.

      As we pointed out earlier, trading for Vinergy Resources on the Canadian exchange under symbol VIN.CN has been halted pending a fundamental change in the company. Through corporate announcements and pure logic it is our assumption that the fundamental change is the completion of the MJ Biopharma acquisition. The hype and speculation that helped skyrocket Vinergy’s stock nearly 200% earlier this year (when we first initiated coverage on the company), could finally be coming to fruition. The hype that drove investors wild just a few months ago could soon be reality.

      While trading of Vinergy in Canada under VIN.CN is halted, trading on the U.S. exchange through symbol VNNYF is picking up in a huge way. We have seen record volume days this week and a consistent, steady climb in share price. It would appear that momentum is in our favor as speculation once again starts to swirl around chat rooms and message boards about what the MJ Biopharma acquisition could mean for VNNYF and its shareholders. For more on why it’s significant and what investors should know about the acquisition, click here.

      What a Scientific Advisory Board Addition Means for the Company’s Cannabis Initiative

      Vinergy recently made a jaw dropping addition to their Scientific Advisory Board that seems to be in line with an MJ Biopharma acquisition. The company recently added John Simon, a senior member of the American Society for Quality, a certified quality auditor and registered quality assurance professional. Mr. Simon has been directly involved with FDA and Health Canada audits of drug manufacturers, testing facilities, and clinical sites.

      Simon assists companies with both site and product licenses. He has helped several companies obtain, renew, and maintain in good standing Drug Establishment Licenses, Medical Device Establishment Licenses, Natural and Non-prescription Site Licenses, and Licenses to Cultivate and Distribute under the Marihuana for medical Purposes Regulations (MMPR which is now under the ACMPR).

      He has extensive experience when it comes to product submissions to both the FDA and Health Canada. Simon will play a key role in driving the company’s cannabis product and technology initiatives. His work could be critical to MJ Biopharma’s long-term strategy of conducting studies out of a state-of-the-art lab focused on identifying specific cannabinoid isolates for targeted therapeutic purposes.

      John Simon could be VNNYF’s bridge to the FDA and Health Canada hopefully ensuring a smooth approval and licensing process for the company. We could be speculating here a bit but it certainly seems like the addition of John Simon was carefully calculated by management and could return tremendous value for the company.

       Disclaimer: Pursuant to an agreement between MAPH and a non-affiliate third party, we were hired for a period of 1 month from 5/1/2017 – 6/1/2017 to publicly disseminate information about (VNNYF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (VNNYF) which we purchased in the open market.We may buy or sell additional shares of (VNNYF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

      0 1742
      marijuana stocks

      Rocky Mountain High Brands Discusses Series A Preferred Restructuring

      DALLAS, March 17, 2017 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water, offered an explanation of its recent move to increase the voting and conversion rights of its Series A Preferred Stock.

      Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, Inc., said, “With the recent acquisition by LSW Holdings, LLC of the Company’s Series A Preferred Stock, we have reviewed our equity structure and are making changes to it to both protect the Company and to provide for its future growth. The Series A Preferred Stock is the Control Block for the Company. It has special rights associated with it and is not designed or intended to be converted to Common Stock. Changes to its voting rights and conversion rights were made to ensure that LSW Holdings maintains control of the Company in the event of corporate actions such as a merger/acquisition or hostile takeover.”

      Welch continued, “Lily Li and other principals and representatives of LSW Holdings were in Dallas this week to meet our Rocky Mountain High team and discuss future plans for the Company. With the opportunities that LSW Holdings will bring into the Company, we need to protect the Company and its shareholders from a hostile takeover or any other uninvited action not in the best interest of the Company or its shareholders. The restructuring of the Series A Preferred Stock voting and conversion rights are a part of that plan.”

      About Rocky Mountain High Brands:

      ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water.

      For interested investors, our stock symbol is RMHB.

      For ordering information please visit: LiveRockyMountainHigh.com

      For corporate information please visit: RockyMountainHighBrands.com

      For information on our high alkaline water visit: EagleSpiritWater.com

      For Rocky Mountain High Distribution Contact:

      Chuck Smith (972) 955-0964
      chuck@rockymountainhighbrands.com

      Visit us on Facebook: https://www.facebook.com/rockymountainhighbrands?fref=nf

      Visit us on Twitter:
      #GetYourHempOn

      Visit us at Investors Hangout: http://investorshangout.com/Rocky-Mountain-High-Brands-Inc-RMHB-69150/

      Investors Hangout is the only authorized Investors blog page for Rocky Mountain High Brands, Inc.

      Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

      Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

      We are your #1 source for all things Marijuana Stocks, Subscribe Below!

      Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
      Ad Placements